Latest Asx News

Patriot Resources has expanded the mineralised footprint at its Kitumba Project in Zambia, doubling the strike length of its key copper-zinc-lead target through advanced geophysical surveys.

Keybridge Capital Limited is navigating a complex recovery with new board leadership, partial loan repayments, and favorable court rulings against former executives. The company is steadily addressing legacy financial and legal challenges.

Western Mines Group advances deep diamond drilling and a high-powered electromagnetic survey at its Mulga Tank project, leveraging co-funded grants to target high-grade nickel sulphide deposits.

Sunshine Metals has upgraded its shallow gold resource at the Liontown prospect by 14%, enhancing contained ounces and grade ahead of a mining study due in January 2026. The company is advancing drilling and environmental permitting as it targets first production next year.

Whitefield Income Limited has successfully completed a $52.9 million placement to wholesale investors, issuing over 40 million new shares amid strong demand. The capital raise leverages the company’s full placement capacity without requiring shareholder approval.

Lion Rock Minerals has kicked off a large-scale infill drilling program at its Minta Est project in Cameroon, focusing on high-value minerals including rutile, zircon, and rare-earth elements monazite and xenotime. This move builds on recent discoveries and a strategic partnership with Tronox Holdings.

Axel REE Limited reports promising metallurgical results from its Caladão Project in Brazil, confirming a magnet-rich ionic clay system with rare earth grades comparable to established Asian operations. These findings underpin a low-capital, low-operating cost in-situ leach development strategy.

Blue Star Helium reports substantial progress on its Galactica helium facility, maintaining its target for first production in December 2025. Key construction and equipment milestones have been achieved, signaling a critical phase in the project’s development.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.

Noronex Limited’s initial drilling at the Powerline Copper Project in Namibia reveals a promising copper-silver mineralised horizon, validating its geological model and prompting further exploration.

Electro Optic Systems has resolved ASIC's investigation into its 2022 revenue guidance breaches by agreeing to a $4 million penalty, paving the way for renewed focus on growth and governance.

Syntara Limited has successfully completed Phase 1a trials for its topical anti-fibrotic drug SNT-9465, demonstrating dose-dependent target engagement and safety, and is now progressing to an innovative Phase 1b study in hypertrophic scars.